Increasing Potassium Intake in Hypertensive Individuals
Primary Purpose
Hypertension
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
High potassium diet
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension focused on measuring Nutrition, Potassium
Eligibility Criteria
Inclusion Criteria:
- Medically treated hypertension as diagnosed Hypertension was established by the participant's cardiologist or if recruited from the online community hypertension was self-reported and confirmed by study investigators based on participant's medical prescription.
- Treatment with an beta blocker, ACE inhibitor, or angiotensin receptor blocker without any adjustment over the previous 3 months
- K+ intake at baseline of less than 80 mmol/day (food diary of 24 hour food recall).
Exclusion Criteria:
- Patients with an episode of acute coronary syndrome, or revascularization within the previous 3 months will not be included.
- Serum K+ concentration 5.0 mmol/L
- Serum creatinine > 130 mmol/L.
- Inability to provide informed consent.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
High potassium diet group
Usual diet group
Arm Description
Individuals in this arm were asked to increase dietary potassium intake over a 4 week period. This was achieved through an increase in consumption of fruits and vegetables.
Individuals in this group were asked to continue habitual dietary intake.
Outcomes
Primary Outcome Measures
Serum potassium concentration
Secondary Outcome Measures
24 hour urinary potassium excretion
3 day dietary food diary
Food record will assess marco and mirco nutrient intake.
Full Information
NCT ID
NCT02759367
First Posted
December 22, 2015
Last Updated
May 23, 2017
Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02759367
Brief Title
Increasing Potassium Intake in Hypertensive Individuals
Official Title
Adequate Intake of Potassium Does Not Cause Hyperkalemia in Hypertensive Individuals on Medications That Antagonize the Renin Angiotensin Aldosterone System
Study Type
Interventional
2. Study Status
Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
March 2008 (undefined)
Primary Completion Date
June 2015 (Actual)
Study Completion Date
June 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study evaluates the safety of increasing dietary potassium intake in a hypertensive population that may be at risk for hyperkalemia.
Detailed Description
The blood pressure lowering benefits of increasing dietary potassium (K⁺) are well known. As such dietary recommendations for hypertension focus on a diet rich in high K⁺ food sources such as fruits and vegetables. An important theme to be addressed is the safety of achieving high dietary K⁺ intake in hypertensive individuals who are also receiving medical therapy that might predispose to elevated serum K⁺ levels (hyperkalemia).
The purpose of this study was to assess the impact of aggressively increasing dietary K⁺ on serum K⁺ concentrations in hypertensive individuals with intact renal function medicated with RAAS blocking drugs. The investigators hypothesized that dietary K⁺ supplementation would not provoke hyperkalemia despite treatment with either an angiotensin converting enzyme (ACEi) or an angiotensin receptor blocker (ARB).
The investigators conducted an open controlled clinical trial in 20 hypertensive subjects with normal renal function who were randomized to a usual diet group (UD n=10), or a high potassium diet group (HKD, n= 10). Fruits and vegetables were used to increase potassium intake. All participants were on an ACEi or and ARB. Serum potassium concentration, 3- day food records and 24 Hour urine collections were completed at baseline and at the end of the 4-week study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Nutrition, Potassium
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Masking Description
Treating physicians and participants were not blinded to randomization. Investigators performing randomization and analysis of dietary intake were blinded.
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
High potassium diet group
Arm Type
Experimental
Arm Description
Individuals in this arm were asked to increase dietary potassium intake over a 4 week period. This was achieved through an increase in consumption of fruits and vegetables.
Arm Title
Usual diet group
Arm Type
No Intervention
Arm Description
Individuals in this group were asked to continue habitual dietary intake.
Intervention Type
Other
Intervention Name(s)
High potassium diet
Intervention Description
An increase in consumption of high potassium fruits and vegetables
Primary Outcome Measure Information:
Title
Serum potassium concentration
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
24 hour urinary potassium excretion
Time Frame
4 weeks
Title
3 day dietary food diary
Description
Food record will assess marco and mirco nutrient intake.
Time Frame
4 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Medically treated hypertension as diagnosed Hypertension was established by the participant's cardiologist or if recruited from the online community hypertension was self-reported and confirmed by study investigators based on participant's medical prescription.
Treatment with an beta blocker, ACE inhibitor, or angiotensin receptor blocker without any adjustment over the previous 3 months
K+ intake at baseline of less than 80 mmol/day (food diary of 24 hour food recall).
Exclusion Criteria:
Patients with an episode of acute coronary syndrome, or revascularization within the previous 3 months will not be included.
Serum K+ concentration 5.0 mmol/L
Serum creatinine > 130 mmol/L.
Inability to provide informed consent.
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
27581475
Citation
Malta D, Arcand J, Ravindran A, Floras V, Allard JP, Newton GE. Adequate intake of potassium does not cause hyperkalemia in hypertensive individuals taking medications that antagonize the renin angiotensin aldosterone system. Am J Clin Nutr. 2016 Oct;104(4):990-994. doi: 10.3945/ajcn.115.129635. Epub 2016 Aug 31.
Results Reference
derived
Learn more about this trial
Increasing Potassium Intake in Hypertensive Individuals
We'll reach out to this number within 24 hrs